Sotera Health Co (NASDAQ:SHC) — Market Cap & Net Worth
Market Cap & Net Worth: Sotera Health Co (SHC)
Sotera Health Co (NASDAQ:SHC) has a market capitalization of $4.57 Billion ($4.57 Billion) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3842 globally and #1313 in its home market, demonstrating a 1.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sotera Health Co's stock price $16.04 by its total outstanding shares 285166994 (285.17 Million). Review SHC current and long-term liabilities to assess the company's total debt and financial obligations.
Sotera Health Co Market Cap History: 2020 to 2026
Sotera Health Co's market capitalization history from 2020 to 2026. Data shows change from $7.82 Billion to $4.57 Billion (-7.72% CAGR).
Index Memberships
Sotera Health Co is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.19% | #87 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.01% | #432 of 3165 |
|
S&P Midcap 400
MID
|
$3.55 Trillion | 0.06% | #287 of 401 |
Weight: Sotera Health Co's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sotera Health Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sotera Health Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.32x
Sotera Health Co's market cap is 4.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
64.53x
Sotera Health Co's market cap is 64.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $7.82 Billion | $818.16 Million | -$38.62 Million | 9.56x | N/A |
| 2021 | $6.72 Billion | $931.48 Million | $116.88 Million | 7.21x | 57.46x |
| 2022 | $2.38 Billion | $1.00 Billion | -$233.57 Million | 2.37x | N/A |
| 2023 | $4.81 Billion | $1.05 Billion | $51.38 Million | 4.58x | 93.53x |
| 2024 | $3.90 Billion | $1.10 Billion | $44.40 Million | 3.55x | 87.87x |
| 2025 | $5.03 Billion | $1.16 Billion | $77.95 Million | 4.32x | 64.53x |
Competitor Companies of SHC by Market Capitalization
Companies near Sotera Health Co in the global market cap rankings as of June 17, 2026.
Key companies related to Sotera Health Co by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Sotera Health Co Historical Marketcap From 2020 to 2026
Between 2020 and today, Sotera Health Co's market cap moved from $7.82 Billion to $ 4.57 Billion, with a yearly change of -7.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.57 Billion | -9.07% |
| 2025 | $5.03 Billion | +28.95% |
| 2024 | $3.90 Billion | -18.81% |
| 2023 | $4.81 Billion | +102.28% |
| 2022 | $2.38 Billion | -64.63% |
| 2021 | $6.72 Billion | -14.18% |
| 2020 | $7.82 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Sotera Health Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.57 Billion USD |
| MoneyControl | $4.57 Billion USD |
| MarketWatch | $4.57 Billion USD |
| marketcap.company | $4.57 Billion USD |
| Reuters | $4.57 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sotera Health Co
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide process… Read more